Ketamine Could Relieve Pain Without Dissociation
A new brain imaging study finds ketamine reduces pain responses independently of the drug's dissociative side effects.
Updated on Oct. 29, 2026 in Substance Abuse
Live Poll
Do you trust medical treatments more if they cause a noticeable physical sensation in your body?
A new brain imaging study shows that ketamine reduces pain responses in the brain independently of the drug's dissociative side effects. This finding helps clarify the pharmacological mechanism of ketamine in potential future pain treatments.
Why it matters
Researchers have long questioned whether patients must experience dissociation—a feeling of detachment—for ketamine to provide pain relief. Separating these effects may lead to new therapeutic strategies that offer relief without the drug's intense psychological impact.
This study of 33 healthy volunteers used fMRI scans to compare brain activity during placebo and ketamine sessions, finding that pain relief occurred regardless of dissociation scores. These results are preliminary and have not yet been replicated in clinical pain populations.
The players
Tel Aviv University
An Israeli public research university that contributed to the study on ketamine's neurological mechanisms.
King's College London
A public research university in the United Kingdom known for its psychiatry and neuroscience research department.
The details
Ketamine appears to reduce pain by dampening activity in brain regions associated with pain response and decreasing connectivity within the brain's default mode network. While researchers found that dissociation also stems from the loosening of connections in this same network, the two processes are distinct. By confirming that pain reduction does not rely on the subjective experience of detachment, the study suggests that future medications could potentially target pain pathways while blocking the drug's dissociative effects.
Timeline
October 29, 2026: The study was published in the journal Neuropsychopharmacology.
Health Landscape
This research provides a new neurological roadmap for the development of NMDA receptor antagonists, which are currently limited by their hallucinogenic side effects. It marks a departure from the assumption that dissociation is a mandatory component of ketamine’s therapeutic profile.
While this study provides important insight into how pain is processed, it remains a preliminary examination of healthy volunteers and does not change clinical practice. Patients currently managing pain should discuss all treatment decisions and concerns about potential side effects with their physician.
The takeaway
Ketamine may provide pain relief through neurological mechanisms that do not require the feeling of dissociation. Patients or caregivers interested in emerging pain research should keep an eye on clinical trial databases for studies testing candidates like lamotrigine designed to block dissociative side effects.
Further reading
For more on the current understanding of therapeutic drug use, visit the Substance Abuse section.
Source note: This article includes information reported by Earth.
Live Poll
Do you trust medical treatments more if they cause a noticeable physical sensation in your body?
